AAAAAA

   
Results: 1-9 |
Results: 9
Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous intervention
Authors: Sdringola, S Assali, AR Ghani, M Moustapha, A Achour, H Yusuf, SW Fujise, K Rosales, O Schroth, GW Anderson, HV Smalling, RW
Citation: S. Sdringola et al., Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous intervention, CATHET C IN, 54(3), 2001, pp. 318-324
Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab ortirofiban)
Authors: Assali, AR Salloum, J Sdringola, S Moustapha, A Ghani, M Hale, S Schroth, G Fujise, K Anderson, HV Smalling, RW Rosales, OR
Citation: Ar. Assali et al., Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab ortirofiban), AM J CARD, 88(8), 2001, pp. 884
Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow-no reflow phenomenon
Authors: Sdringola, S Assali, A Ghani, M Yepes, A Rosales, O Schroth, GW Fujise, K Anderson, HV Smalling, RW
Citation: S. Sdringola et al., Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow-no reflow phenomenon, CATHET C IN, 51(4), 2000, pp. 394-399
Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of "no reflow" phenomenon
Authors: Assali, AR Sdringola, S Ghani, M Denkats, AE Yepes, A Hanna, GP Schroth, G Fujise, K Anderson, HV Smalling, RW Rosales, OR
Citation: Ar. Assali et al., Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of "no reflow" phenomenon, CATHET C IN, 51(1), 2000, pp. 27-31
Timing of coronary stent thrombosis in patients treated with prophylactic tirofiban
Authors: Assali, AR Sdringola, S Ghani, M Westbrook, LA Anderson, HV Schroth, G Fujise, K Smalling, RW Rosales, OR
Citation: Ar. Assali et al., Timing of coronary stent thrombosis in patients treated with prophylactic tirofiban, J INVAS CAR, 12(9), 2000, pp. 460-463
Balloon to artery ratio, not inflation pressure, correlates with adequate stent deployment: Size is more important than pressure
Authors: Fujise, K Yhip, PA Anderson, HV Schroth, G Rosales, O Smalling, RW
Citation: K. Fujise et al., Balloon to artery ratio, not inflation pressure, correlates with adequate stent deployment: Size is more important than pressure, J INTERV CA, 13(4), 2000, pp. 223-229
Regulation of apoptosis and cell cycle progression by MCL1 - Differential role of proliferating cell nuclear antigen
Authors: Fujise, K Zhang, D Liu, JL Yeh, ETH
Citation: K. Fujise et al., Regulation of apoptosis and cell cycle progression by MCL1 - Differential role of proliferating cell nuclear antigen, J BIOL CHEM, 275(50), 2000, pp. 39458-39465
Causes of early reintervention after successful coronary artery stenting
Authors: Assali, AR Sdringola, S Ghani, M Moustapha, A Anderson, HV Schroth, G Fujise, K Smalling, RW Rosales, O
Citation: Ar. Assali et al., Causes of early reintervention after successful coronary artery stenting, AM J CARD, 86(9), 2000, pp. 1018-1021
Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no-reflow phenomenon
Authors: Hanna, GP Yhip, P Fujise, K Schroth, GW Rosales, OR Anderson, HV Smalling, RW
Citation: Gp. Hanna et al., Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no-reflow phenomenon, CATHET C IN, 48(3), 1999, pp. 275-278
Risultati: 1-9 |